News | November 02, 2023
Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Subscribe To Our Newsletter & Stay Updated
